PubMed · 2014 · 40 citations · 7 references
Our findings showed that the use of HRIG was low with less than 2 per cent of the Category III patients being prescribed it. As vaccine and HRIG continue to remain expensive, the intradermal vaccine, shorter regimes like the Zagreb regime and monoclonal antibodies may offer safer and cost-effective options in the future. Further studies need to be done in different parts of the country.
7
WHO Expert Consultation on Rabies
Tiziana Lembo · 2010 · 349 citations
Expert Consultation 2013, Rabies Second Report, Medical Ethics +8